John Sigle, DPM
Primary Podiatric Medicine · Springfield, ILNPI 1174502868
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $25,643 of the $35,338 with a category attached, or 72.6%. Medical Device Business Services, Inc. accounts for 67.1% of it on its own, with 10 other manufacturers making up the rest. Among primary podiatric medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 116 payments — averaging $304.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$24K
- Johnson & Johnson$10K
- Stryker$948
- Amgen$493
- Royal Biologics, Inc.$119
- In2bones USA, LLC$115
- plus $210 from 5 others
Across 136 payments — averaging $2254.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endo Pharmaceuticals Inc.$148K
- Ipsen Innovation$50K
- Organogenesis Inc.$42K
- Integra Lifesciences Corporation$34K
- Axogen$30K
- Bristol Myers Squibb$2K
What the payments were for
- Consulting fees$25,64373%
- Travel & lodging$6,27718%
- Food & beverage$3,41810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 38 | $23,722 |
| Johnson & Johnson | 35 | $9,731 |
| Stryker(2 entities) | 29 | $948 |
| Amgen(2 entities) | 4 | $493 |
| Royal Biologics, Inc. | 1 | $119 |
| In2bones USA, LLC | 1 | $115 |
| ETS Wound Care LLC | 1 | $80 |
| Melinta Therapeutics, LLC | 4 | $71 |
| Biowound Solutions, Inc. | 1 | $28 |
| Polarityte, Inc. | 1 | $20 |
| Osiris Therapeutics Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NA$9,625
- MOTOBAND$4,903
- FMS$1,109
- HEADLESS COMPRESSION SCREWS$540
- PROstep$510
- KRYSTEXXA$493
- HAMMERLOCK$216
- Fibulink$150
- CARTIVA$126
- MaxxCell$119
- Quantum Total Ankle$115
- BME NITINOL CONTINUOUS COMPRESSION IMPLANTS$105
How this compares
$35,338 in reported general payments places this provider in the 95th percentile of 23 primary podiatric medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 30 | $8,773 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 49 | $564 |
| Meloxicam | 44 | $131 |
| Cephalexin | 25 | $97 |
| Terbinafine Hcl | 23 | $73 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Springfield
- Jennifer BernsteinLibertyville$10K
- Corey CzarneckiChicago$2K
- Andrew OkeefeChicago$1K
- Matthew KeeneRockford$1K
- Gregory JansynBloomingdale$1K
- Muhammad HussainChicago$592
- Jennifer KaletaNaperville$487
- Raymond HanzelinBerwyn$273
- Magdala LafontantChicago$230
- Rachel GriederPeoria$227
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.